EUVIMEDEUVIMED entdecken
Crossref

Advanced Glycation End Products Induced Mitochondrial Dysfunction of Chondrocytes through Repression of AMPKα-SIRT1-PGC-1α Pathway

Qingshan Yang, Yucong Shi, Tao Jin, Bowen Duan, Shujin Wu

Pharmacology · 2022 · 107 (5-6) · 298-307

DOI: 10.1159/000521720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 03.03.2022. Verfasst von Qingshan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Gan Su Province Hospital, Lan Zhou, China. Hauptthemen laut MEDLINE: Osteoarthritis, Sirtuin 1. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Our previous studies have demonstrated advanced glycation end products (AGEs) was an important mediator in osteoarthritis (OA) which may induce mitochondrial dysfunction. AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), and its downstream target peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) are the critical sensors that regulate mitochondrial biogenesis and have been recognized as therapeutic targets in OA. This study was designed to test whether AGEs caused mitochondrial dysfunction through modulation of AMPKα/SIRT1/PGC-1α.

Methods

We knocked down or overexpressed AMPKα, SIRT1, and PGC-1α by small interfering RNA or plasmid DNA transfection, respectively. Mitochondrial membrane potential (△Ψ) was detected by tetraethylbenzimidazolyl carbocyanine iodide (JC-1) fluorescence probe.

Results

The results showed that AGEs impaired △Ψ, intracellular ATP level, and mitochondrial DNA content, linked to decreased AMPKα, SIRT1, and PGC-1α expression in chondrocyte. AMPKα pharmacologic activation or overexpression of AMPKα, SIRT1, and PGC-1α reversed impairments of mitochondrial biogenesis, oxidative stress, and inflammation in AGEs-induced chondrocytes. However, AMPKα activation using AICAR had decreased capacity to increase each of those same effect readouts in AGEs-treated SIRT1-siRNA or PGC-1α-siRNA chondrocyte.

Conclusion

Taken together, AGEs reduced the AMPKα/SIRT1/PGC-1α signaling in chondrocytes, leading to mitochondrial dysfunction as a result of increased oxidative stress, inflammation, and apoptosis. These results indicated that target AMPK may be as a novel therapeutic strategy for AGEs-related OA prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisSirtuin 1AMP-Activated Protein KinasesChondrocytesGlycation End Products, AdvancedHumansInflammationMitochondriaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRNA, Small Interfering

Stichwörter der Autor:innen

AMP-activated protein kinaseAdvanced glycation end productsMitochondrial dysfunctionPeroxisome proliferator-activated receptor gamma coactivator-1αSirtuin 1

Substanzen

Glycation End Products, AdvancedPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRNA, Small InterferingAMP-Activated Protein KinasesSIRT1 protein, humanSirtuin 1

Autor:innen und Institutionen

  • Department of Orthopaedics, Gan Su Province Hospital, Lan Zhou, China.
  • Gansu University of Chinese Medicine, Lan Zhou, China.
  • Department of Pharmacy, Gan Su ProvincTe Hospital, Lan Zhou, China.

Zitieren

APA

Yang, Q., Shi, Y., Jin, T., Duan, B., & Wu, S. (2022). Advanced Glycation End Products Induced Mitochondrial Dysfunction of Chondrocytes through Repression of AMPKα-SIRT1-PGC-1α Pathway. Pharmacology, 107(5-6), 298-307. https://doi.org/10.1159/000521720

Vancouver

Yang Q, Shi Y, Jin T, Duan B, Wu S. Advanced Glycation End Products Induced Mitochondrial Dysfunction of Chondrocytes through Repression of AMPKα-SIRT1-PGC-1α Pathway. Pharmacology. 2022;107(5-6):298-307. doi:10.1159/000521720

BibTeX
@article{Yang2022,
  author = {Yang, Qingshan and Shi, Yucong and Jin, Tao and Duan, Bowen and Wu, Shujin},
  title = {Advanced Glycation End Products Induced Mitochondrial Dysfunction of Chondrocytes through Repression of AMPKα-SIRT1-PGC-1α Pathway},
  journal = {Pharmacology},
  year = {2022},
  volume = {107},
  number = {5-6},
  pages = {298--307},
  doi = {10.1159/000521720}
}
Kostenlos starten →